tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CGEM Stock Latest News

Cullinan: Buy Rating Reiterated on 2026 Clinical Catalysts and Undervalued Pipeline Upside
RatingsCullinan: Buy Rating Reiterated on 2026 Clinical Catalysts and Undervalued Pipeline Upside
11d ago
CGEM
Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright
PremiumThe Fly
Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright
11d ago
CGEM
Cullinan Management Outlines Catalyst-Rich 2026 Pipeline Outlook
PremiumCompany Announcements
Cullinan Management Outlines Catalyst-Rich 2026 Pipeline Outlook
11d ago
8K
CGEM
Cullinan Therapeutics price target raised to $30 from $28 at Morgan Stanley
PremiumThe Fly
Cullinan Therapeutics price target raised to $30 from $28 at Morgan Stanley
11d ago
CGEM
Cullinan Therapeutics provides corporate update, anticipated 2026 milestones
PremiumThe Fly
Cullinan Therapeutics provides corporate update, anticipated 2026 milestones
11d ago
CGEM
Cullinan Therapeutics price target raised to $33 from $22 at Clear Street
PremiumThe FlyCullinan Therapeutics price target raised to $33 from $22 at Clear Street
1M ago
CGEM
Cullinan Therapeutics price target raised to $34 from $25 at Wedbush
Premium
The Fly
Cullinan Therapeutics price target raised to $34 from $25 at Wedbush
1M ago
CGEM
Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan
Premium
Ratings
Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan
1M ago
CGEM
Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position
PremiumRatings
Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position
1M ago
CGEM
Optimistic Buy Rating for Cullinan Management Driven by Promising CLN-049 Therapy Results
PremiumRatings
Optimistic Buy Rating for Cullinan Management Driven by Promising CLN-049 Therapy Results
1M ago
CGEM
Cullinan Therapeutics Presents Promising CLN-049 Data
PremiumCompany Announcements
Cullinan Therapeutics Presents Promising CLN-049 Data
1M ago
8K
CGEM
Cullinan Therapeutics shares updated clinical data from Phase 1 study of CLN-049
PremiumThe Fly
Cullinan Therapeutics shares updated clinical data from Phase 1 study of CLN-049
1M ago
CGEM
Cullinan Therapeutics receives FDA fast track designation for CLN-049
PremiumThe FlyCullinan Therapeutics receives FDA fast track designation for CLN-049
2M ago
CGEM
Buy Rating for Cullinan Therapeutics Driven by Promising AML Treatment Developments and Strong Market Potential
Premium
Ratings
Buy Rating for Cullinan Therapeutics Driven by Promising AML Treatment Developments and Strong Market Potential
2M ago
CGEM
Cullinan Therapeutics price target raised to $38 from $32 at BTIG
Premium
The Fly
Cullinan Therapeutics price target raised to $38 from $32 at BTIG
2M ago
CGEM
Cullinan Management Ends Development of CLN-617
PremiumCompany Announcements
Cullinan Management Ends Development of CLN-617
2M ago
8K
CGEM
Promising Developments and Strategic Partnerships Boost Cullinan Management’s Growth Prospects
PremiumRatings
Promising Developments and Strategic Partnerships Boost Cullinan Management’s Growth Prospects
2M ago
CGEM
Taiho, Cullinan Therapeutics initiate rolling submission of NDA for zipalertinib
PremiumThe Fly
Taiho, Cullinan Therapeutics initiate rolling submission of NDA for zipalertinib
2M ago
CGEM
Optimistic Buy Rating for Cullinan Management Driven by Promising Drug Pipeline and Upcoming Catalysts
PremiumRatings
Optimistic Buy Rating for Cullinan Management Driven by Promising Drug Pipeline and Upcoming Catalysts
2M ago
CGEM
Cullinan Therapeutics price target raised to $26 from $24 at H.C. Wainwright
PremiumThe FlyCullinan Therapeutics price target raised to $26 from $24 at H.C. Wainwright
2M ago
CGEM
Cullinan Management’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
Premium
Ratings
Cullinan Management’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
2M ago
CGEM
Cullinan Therapeutics Reports Increased Q3 Losses
Premium
Company Announcements
Cullinan Therapeutics Reports Increased Q3 Losses
2M ago
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >